Zobrazeno 1 - 10
of 76
pro vyhledávání: '"N. I Kapranov"'
Autor:
L. R Avetisyan, M. Yu Chernukha, I. A Shaginyan, N. I Kapranov, E. A Siyanova, O. S Medvedeva, E. I Kondratieva, G. V Alekseeva, S. A Krasovsky, M. V Usacheva, E. L Amelina
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 92, Iss 6, Pp 3-10 (2015)
Aim. Study the spectrum of resistance to antibiotics and its variability of Staphylococcus aureus, Pseudomonas aeruginosa and Вurkholderia cepacia complex (BCC), persisting in lungs of MV patients. Materials and methods. 312 strains of S. aureus, 21
Externí odkaz:
https://doaj.org/article/5481061f862c42e7ad083c02641e1c2f
Autor:
S. V. POLIKARPOVA, E. I. KONDRATYEVA, L. A. SHABALOVA, N. V. PIVKINA, S. V. ZHILINA, A. Y. VORONKOVA, V. D. SHERMAN, V. S. NIKONOVA, N. I. KAPRANOV, N. Y. KASHIRSKAYA, S. Y. SEMYKIN, E. L. AMELINA, S. A. KRASOVSKY
Publikováno v:
Медицинский совет, Vol 0, Iss 15, Pp 84-89 (2016)
Chronic lower respiratory tract infection in patients with cystic fibrosis (CF) is the major factor determining the severity of the clinical course and prognosis of the disease. The purpose of the study was to investigate the prevailing respiratory m
Externí odkaz:
https://doaj.org/article/9fde4088c52346b292623b7a73c2d83c
Autor:
N. Yu. Kashirskaya, S. A. Krasovsky, A. V. Chernyak, V. D. Sherman, A. Yu. Voronkova, L. A. Shabalova, V. S. Nikonova, Yu. V. Gorinova, O. I. Simonova, E. L. Amelina, E. I. Kondrat’eva, N. I. Kapranov, N. V. Petrova, R. A. Zinchenko
Publikováno v:
Вопросы современной педиатрии, Vol 14, Iss 4, Pp 503-508 (2015)
Cystic fibrosis is multiple organ pathology that requires a complex treatment. Its standardization and pharmacoeconomic analysis are absolutely necessary. We performed a retrospective analysis of the trends in life expectancy of cystic fibrosis patie
Externí odkaz:
https://doaj.org/article/469ac005c5ab44a3b76219cbd0d47e2f
Autor:
Ye. L. Amelina, I. K. Asherova, I. K. Volkov, Т. Ye. Gembitskaya, Ye. K. Ginter, N. А. Il’yenkova, N. I. Kapranov, I. P. Karimova, N. Yu. Kashirskaya, Ye. I. Kondrat’yeva, М. N. Kostyleva, S. А. Krasovsky, N. B. Merzlova, L. P. Nazarenko, L. S. Namazova-Baranova, А. F. Neretina, V. S. Nikonova, А. V. Orlov, S. S. Postnikov, Т. А. Protasova, S. Yu. Semykin, D. F. Sergienko, О. I. Simonova, I. D. Uspenskaya, М. Yu. Chernukha, L. А. Shabalova, I. А. Shaginyan, V. D. Sherman
Publikováno v:
Вопросы современной педиатрии, Vol 13, Iss 6, Pp 89-95 (2014)
The pulmonary drug administration for the treatment of a pulmonary affection in cystic fibrosis is highly effective. This consensus document summarizes data on inhalation intake of bronchodilators, mucolytics, anti-inflammatory drugs, including gluco
Externí odkaz:
https://doaj.org/article/6524667aa0ed4fb08cf3767cd4dcf923
Autor:
A. A. Baranov, N. I. Kapranov, N. Yu. Kashirskaya, L. S. Namazova-Baranova, V. D. Sherman, O. I. Simonova, A. Yu. Tomilova, K. V. Sevost'yanov, A. M. Pushkov, A. L. Vladykin, N. V. Shatokhin
Publikováno v:
Педиатрическая фармакология, Vol 11, Iss 6, Pp 16-23 (2014)
Mucoviscidosis is a monogenic autosomal recessive caused by the CFTR gene mutations and characterized by pronounced genetic heterogeneity and clinical polymorphism, which emphasizes the need in comprehensive diagnosis and molecular-genetic verificati
Externí odkaz:
https://doaj.org/article/1f3392869bb041e986e8b98f6eda98a2
Autor:
N. I. Kapranov
Publikováno v:
Медицинский совет, Vol 0, Iss 11, Pp 62-69 (2013)
Respiratory infection in cystic fibrosis develops in the first years of life and plays a key role in shaping the prognosis of the disease. Microbiology of respiratory infection in such patients is significantly different from that in patients without
Externí odkaz:
https://doaj.org/article/60775db72cca4f9d8c1cca7d2de14d87
Publikováno v:
Педиатрическая фармакология, Vol 10, Iss 6, Pp 53-60 (2013)
The article is dedicated to historical and modern trials in the sphere of mucoviscidosis in Russia, peculiarities of clinical manifestations, pathophysiological and pathomorphological disorders and of the disease course with the analysis of the first
Externí odkaz:
https://doaj.org/article/30ce49665a1b4b69bd1971897f163601
Autor:
S. A. Krasovskii, V. S. Nikonova, N. Yu. Kashirskaya, E. I. Kondrat'eva, A. V. Chernyak, N. I. Kapranov, E. L. Amelina, V. D. Sherman, V. A. Samoilenko, A. Yu. Voronkova, L. A. Shabalova, O. I. Simonova, M. V. Usacheva, V. V. Chernikov
Publikováno v:
Вопросы современной педиатрии, Vol 12, Iss 1, Pp 17-23 (2013)
The aim of this study was to assess different clinical and genetic, microbiological and functional features of patients with cystic fibrosis living in Moscow and Moscow region on the 31st December, 2010. The mean age of the patients was 12,1±9,6 yea
Externí odkaz:
https://doaj.org/article/f51de47f38dc47499787b8f479273248
Publikováno v:
Вопросы современной педиатрии, Vol 11, Iss 4, Pp 54-59 (2012)
Cystic fibrosis is a common hereditary disease, characterized by multiple organ dysfunction, including early and severe involvement of respiratory system. The disease is caused by CFTR (cystic fibrosis transmembrane conductance regulator) gene mutati
Externí odkaz:
https://doaj.org/article/39cca4f94a574c70abf09ebf685c76e1
Autor:
I. K. Asherova, N. I. Kapranov
Publikováno v:
Педиатрическая фармакология, Vol 9, Iss 3, Pp 96-101 (2012)
The creation of a register of mucoviscidosis (MV) patients is necessary for determining the epidemic situation in the region, evaluating the efficacy of therapeutic strategies and the quality of healthcare provided. The regional register of Yaroslavl
Externí odkaz:
https://doaj.org/article/7ea14b7a146b448ea02672283c80e234